Review: Deep Learning-Based Survival Analysis of Omics and Clinicopathological Data

Abstract

The 2017–2024 period has been prolific in the area of the algorithms for deep-based survival analysis. We have searched the answers to the following three questions. (1) Is there a new “gold standard” already in clinical data analysis? (2) Does the DL component lead to a notably improved performance? (3) Are there tangible benefits of deep-based survival that are not directly attainable with non-deep methods? We have analyzed and compared the selected influential algorithms devised for two types of input: clinicopathological (a small set of numeric, binary and categorical) and omics data (numeric and extremely high dimensional with a pronounced p >> n complication).